An Introduction to Vaccines: An Old Problem in a New Setting

  • E. S. Lennox


The story of modern vaccine development begins with Jenner 200 years ago and today smallpox has been completely eradicated. This unique and remarkable achievement has been accomplished in part because vaccinia meets so well the requirement of a good vaccine (Table 1). No less important, however, has been the mobilisation of social, political and economic resources around the world coordinated by the World Health Organisation. The will to do the job and an effective strategy coupled to an almost ideal vaccine made this possible.


Respiratory Syncytial Virus Peptide Vaccine Vaccine Design Human Rabies Ideal Vaccine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Barteling JA (1988) Possibilities and limitations of synthetic peptide vaccines in biotechnology in Advances in Biotechnological Process 10 Ed. M. Mizrahi, Alan Liss, New York.Google Scholar
  2. Bruggemann M, Neuberger M S (1988) Novel antibodies by genetic manipulation progress in allergy. 45: 91–105Google Scholar
  3. Dougan D, Maskell D, O’Callaghan D, Chatfield S, Charles I, Hormaeche C (1988) Oral vaccination. Antonie van Leeuwenhoek 54: 447–451PubMedCrossRefGoogle Scholar
  4. Hruby DE (1988) Present and future application of vaccinia virus as a vector. Vet Parasitol 29:281–292PubMedCrossRefGoogle Scholar
  5. Murphy BR, Prince GA, Collins PL, Coelingh KVW, Olmstead RA, Spriggs MK, Parrott RH, Kim HW, Brandt CD, Channock RM (1988) Current approaches to the development of vaccines effective against parainfluenza and respiratory syncytial viruses. Virus Res 11:1–15PubMedCrossRefGoogle Scholar
  6. Perrin LH, Simitsek P, Srivastava I (1988) Development of malaria vaccines. Trop Geogr Med 40: 56–521Google Scholar
  7. Rothbard J (1989) High degeneracy of HLA DR peptide interactions:possible ramifications in vaccine design. This symposium.Google Scholar
  8. Russell MW, Mestecky J (1988) Induction of the mucosal immune response. Rev infect dis 10: S440-S446PubMedCrossRefGoogle Scholar
  9. Vodopija I (1988) Current issues in human rabies immunization.Rev Infect Dis 10: S758-S763PubMedCrossRefGoogle Scholar
  10. Zuckerman AJ, (1988) The development of novel hepatitis B vaccines. Biochem Soc Symp 53: 39–49Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • E. S. Lennox

There are no affiliations available

Personalised recommendations